Exodus Point Capital Management, LP Context Therapeutics Inc. Transaction History
Exodus Point Capital Management, LP
- $14.7 Billion
- Q2 2024
A detailed history of Exodus Point Capital Management, LP transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 24,750 shares of CNTX stock, worth $54,450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,750Holding current value
$54,450% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CNTX
# of Institutions
38Shares Held
57.2MCall Options Held
0Put Options Held
0-
Nextech Invest Ag7.42MShares$16.3 Million2.8% of portfolio
-
Deep Track Capital, LP Greenwich, CT7.42MShares$16.3 Million0.49% of portfolio
-
Great Point Partners LLC Greenwich, CT7.42MShares$16.3 Million3.93% of portfolio
-
Avidity Partners Management LP Dallas, TX7.42MShares$16.3 Million0.73% of portfolio
-
Blue Owl Capital Holdings LP New York, NY5.16MShares$11.4 Million4.29% of portfolio
About Context Therapeutics Inc.
- Ticker CNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,966,100
- Market Cap $35.1M
- Description
- Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...